Table 3.
| ||||||
Group | Control | L-carnitine | Diabetic | Diabetic + LC50 | Diabetic + LC100 | Diabetic + LC200 |
STD (µm) | 285.7 ± 15.81 | 287.5 ± 15.43 | 249.9 ± 10.86*** | 251.5 ± 13.06 | 256.1 ± 12.34 | 10.94 ± 261.5***,** |
EGH (µm) | 92.10 ± 10.21 | 94.72 ± 10.10 | 54.10 ± 11.98*** | 56.80 ± 11.37 | 59.80 ± 11.34 | 64.00 ± 14.29***,* |
Johnson’s scores | 9.19 ± 0.39 | 9.22 ± 0.53 | 6.06 ± 0.75*** | 6.21 ± 0.70 | 7.39 ± 1.05* | 8.08 ± 0.83***,** |
Note: The data are expressed as mean SD. Statistical significance is represented as follows: (*p 0.05, **p 0.01, ***p 0.001) : compared with control group; : compared with diabetic group; : compared doses of LC 200, 100 with LC50. STD: seminiferous tubule diameter; GEH: Germinal epithelium height; LC: L-carnitine |